CRP and polycystic ovary syndrome: However, cystatin C (as a marker of CKD) was reduced, the change in decay accelerator factor (that is protective against complement activation) was decreased, and CRP was positively correlated with eGFR in the PCOS-SGH group, suggesting that inflammation may be important at higher GH.